Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans

Alcohol and Alcoholism

Volumn 47, Issue 3, 2012, Pages 226-232

  Feuerecker, Matthias ^a   Hauer, Daniela ^a   Gresset, Theresa ^a   Lassas, Simone ^a   Kaufmann, Ines ^a   Vogeser, Michael ^b   Briegel, Josef ^a   Hornuss, Cyrill ^a   Choukèr, Alexander ^a   Schelling, Gustav ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; GLUCOSE;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENDOCANNABINOID BLOOD LEVEL; FEMALE; FLUID INTAKE; GLUCOSE BLOOD LEVEL; GRAPE JUICE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RED WINE; SEX DIFFERENCE;

ADULT; ALCOHOL DRINKING; ARACHIDONIC ACIDS; BLOOD GLUCOSE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ENDOCANNABINOIDS; ETHANOL; FEMALE; GLYCERIDES; HUMANS; MALE; POLYUNSATURATED ALKAMIDES; WINE;

ANIMALIA; VITACEAE;

EID: 84860251790     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agr162     Document Type: Article

References (41)

1. Basavarajappa BS, Hungund BL. (1999) Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. J Neurochem 72:522-8.
2. Basavarajappa BS, Saito M, Cooper TB et al. (2000) Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim Biophys Acta 1535:78-86.
3. Basavarajappa BS, Saito M, Cooper TB et al. (2003) Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur J Pharmacol 466:73-83.
4. Boden JM, Fergusson DM. (2011) Alcohol and depression. Addiction 106:906-14.
5. Brien SE, Ronksley PE, Turner BJ et al. (2011) Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. Br Med J 342:d636.
6. Centonze D, Battistini L, Maccarrone M. (2008) The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. Curr Pharm Des 14:2370-2382.
7. Cippitelli A, Bilbao A, Hansson AC et al. (2005) Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci 21:2243-51.
8. Colombo G, Serra S, Brunetti G et al. (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanolpreferring sP rats. Psychopharmacology (Berl) 159:181-7.
9. Cote M, Matias I, Lemieux I et al. (2007) Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (Lond) 31:692-9.
10. De Petrocellis L, Di Marzo V. (2009) An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab 23:1-15.
11. Di Marzo V. (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7:438-55.
12. Di Marzo V, Melck D, Bisogno T et al. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521-8.
13. Di Marzo V, Goparaju SK, Wang L et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822-5.
14. Di Marzo V, Izzo AA. (2006) Endocannabinoid overactivity and intestinal inflammation. Gut 55:1373-6.
15. Di Marzo V, Verrijken A, Hakkarainen A et al. (2009) Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. Eur J Endocrinol 161:715-22.
16. Erlanson-Albertsson C, Lindqvist A. (2010) Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids. Regul Pept 161:87-91.
17. Ferrer B, Bermudez-Silva FJ, Bilbao A et al. (2007) Regulation of brain anandamide by acute administration of ethanol. Biochem J 404:97-104.
18. Feuerecker M, Hauer D, Toth R et al. (2011) Effects of exercise stress on the endocannabinoid system in humans under field conditions. Eur J Appl Physiol. [Epub ahead of print].
19. Gatta-Cherifi B, Matias I, Vallee M et al. (2011) Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. Int J Obes (Lond). [Epub ahead of print].
20. Gessa GL, Serra S, Vacca G et al. (2005) Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcoholpreferring sP rats. Alcohol Alcohol 40:46-53.
21. Gonsiorek W, Lunn C, Fan X et al. (2000) Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol Pharmacol 57:1045-50.
22. Gonzalez S, Cascio MG, Fernandez-Ruiz J et al. (2002) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73-81.
23. Gonzalez S, Valenti M, de Miguel R et al. (2004) Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. Br J Pharmacol 143:455-64.
24. Hill MN, Miller GE, Carrier EJ et al. (2009) Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34:1257-68.
25. Jesudason D, Wittert G. (2008) Endocannabinoid system in food intake and metabolic regulation. Curr Opin Lipidol 19:344-8.
26. Joosten MM, Balvers MG, Verhoeckx KC et al. (2010) Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and nonfasting conditions in women. Nutr Metab (Lond) 7:49.
27. Lazarus R, Sparrow D, Weiss ST. (1997) Alcohol intake and insulin levels. The normative aging study. Am J Epidemiol 145:909-16.
28. Malinen H, Hyytia P. (2008) Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats. Alcohol Clin Exp Res 32:1976-83.
29. Matias I, Gonthier MP, Orlando P et al. (2006) Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 91:3171-80.
30. Matias I, Di Marzo V. (2007) Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 18:27-37.
31. Mitchell PB, Morris MJ. (2007) Depression and anxiety with rimonabant. Lancet 370:1671-2.
32. Pacher P. (2009) Cannabinoid CB1 receptor antagonists for atherosclerosis and cardiometabolic disorders: new hopes, old concerns? Arterioscler Thromb Vasc Biol 29:7-9.
33. Ronksley PE, Brien SE, Turner BJ et al. (2011) Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. Br Med J 342:d671.
34. Rubio M, McHugh D, Fernandez-Ruiz J et al. (2007) Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. Neurosci Lett 421:270-4.
35. Rubio M, de Miguel R, Fernandez-Ruiz J et al. (2009) Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas. Drug Alcohol Depend 99:354-8.
36. Sanger GJ. (2007) Endocannabinoids and the gastrointestinal tract: what are the key questions? Br J Pharmacol 152:663-70.
37. Scheen AJ, Finer N, Hollander P et al. (2006) Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 368:1660-72.
38. Sugamura K, Sugiyama S, Nozaki T et al. (2009) Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation 119:28-36.
39. Vogeser M, Hauer D, Christina Azad S et al. (2006) Release of anandamide from blood cells. Clin Chem Lab Med 44:488-91.
40. Vogeser M, Schelling G. (2007) Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples. Clin Chem Lab Med 45:1023-5.
41. Zimmermann US, Buchmann A, Steffin B et al. (2007) Alcohol administration acutely inhibits ghrelin secretion in an experiment involving psychosocial stress. Addict Biol 12:17-21.